ID: ALA4750318

Max Phase: Preclinical

Molecular Formula: C20H30O3

Molecular Weight: 318.46

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCC/C=C/c1cccc(C(=O)O)c1O

Standard InChI:  InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-14-17-15-13-16-18(19(17)21)20(22)23/h12-16,21H,2-11H2,1H3,(H,22,23)/b14-12+

Standard InChI Key:  YNMUZEACBQFQEH-WYMLVPIESA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.46Molecular Weight (Monoisotopic): 318.2195AlogP: 6.02#Rotatable Bonds: 12
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.74CX Basic pKa: CX LogP: 7.55CX LogD: 4.05
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.46Np Likeness Score: 0.81

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source